EMD Serono, Inc · Rockland, MA United States
Company Description
View EMD Serono, Inc Locations On A US Map
This link will open in a new window
This link will open in a new window EMD Serono (formerly Serono) is serious when it comes to fighting disease. The company develops a variety of recombinant prescription medicines used in the treatment of neurological, fertility, oncology, and metabolic disorders and diseases such as multiple sclerosis, lupus, and HIV. EMD Serono conducts research and development programs and markets products such as Gonal-f, Luveris, Ovidrel, Rebif, and Zorbtive in the US and Canada. The company is the North American operating subsidiary of Merck Serono S.A. , (formerly Serono S.A.) which was acquired by Merck KGaA in 2007. To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Key EMD Serono, Inc Financials
| Company Type | Subsidiary Headquarters |
| Fiscal Year-End | December |
| Employees | 623 |
EMD Serono, Inc Executives
13 executives listed for EMD Serono, Inc's Rockland, MA location.
| Title | Name & Bio | Contact |
| President and CEO | Fereydoun Firouz | Network |
| VP US Operations and Process Innovation | John Huycke | Network |
| CFO | Stefan Rupp | Network |
Competition
Competitive Landscape for EMD Serono, Inc
Demand often depends on the income of consumers or the profitability of business customers, because many technology products and services are expensive. The profitability of individual companies is driven by their ability to develop and market new products. Large companies often have advantages in access to capital and marketing. Small companies can compete successfully if they have expertise in a particular field of knowledge. The industry is capital-intensive: average annual revenue per worker is nearly $300,000. To read the full description, subscribe now.Top EMD Serono, Inc Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!